HOME >> MEDICINE >> NEWS
People with large pupils can now get LASIK and avoid night vision disturbances

SAN FRANCISCO People who previously were not considered good candidates for LASIK because of large pupils can now get the procedure, according to a study appearing in the July issue of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, the Eye M.D. Association. By using a larger laser treatment zone on the underlying layers of the cornea, surgeons can avoid inducing night vision disturbances such as haloes and glare that patients with large pupils often experience.

In this study, the first to evaluate laser treatment zones larger than 6.5 millimeters, 352 eyes of 186 patients underwent LASIK for correction of nearsightedness and nearsightedness with astigmatism. The treatment zones varied from six to eight millimeters, depending on the size of the patient's pupil, degree of astigmatism and amount of needed correction.

Among patients with nearsightedness, nearly 56 percent achieved uncorrected visual acuity of 20/20 or better; among those with nearsightedness with astigmatism, nearly 62 percent achieved 20/20 or better. In addition, preoperative best-corrected visual acuity and best spectacle-corrected contrast sensitivity were maintained.

Brian S. Boxer Wachler, MD, co-author of the study and a faculty member at the UCLA Medical Center, Jules Stein Eye Institute, said, "We know that corneal aberrations and night vision disturbances after LASIK are directly proportional to the degree of nearsightedness corrected and the size of the clearance zone that is, the difference between pupil size and the optical zone treated by the laser. With this study, we now know use of large optical zones is safe and effective in preventing nighttime glare and haloes in patients with large pupils."

"This study shows using ablation zones from six to eight millimeters did not pose a problem in terms of safety. If anything, the larger optical zones had a higher percentage of eyes achieving 20/20 and 20/40 uncorrected visual acuity than th
'"/>

Contact: Media Relations
pgreene@aao.org
415-561-8534
American Academy of Ophthalmology
24-Jul-2003


Page: 1 2

Related medicine news :

1. People wounded in tsunami at risk of undetected fungal infections
2. People on food stamps cant afford heart-healthy meals
3. People are of two minds on moral judgments
4. People with low incomes more likely to develop brain tumors
5. People are averse to taking drugs
6. People with chronic eye diseases not getting recommended eye exams
7. People only slightly more likely to die after episodes of stagnant air
8. People with food allergies should not only be careful about what they eat
9. People who give, live longer: U-M study shows
10. People near freeways are exposed to 30 times the concentration of dangerous particles
11. People who dont dip have higher levels of clot factor and risk

Post Your Comments:
(Date:10/22/2014)... only 24 hours in a day, that doesn’t seem to be ... their busy schedules for exercise and fitness. Fortunately, one does not ... shape. Here are five ways you can reach your fitness and ... Commute , Consider riding a bike or taking the bus or ... If you must use your car to get to work, start ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market Forecasts ... facts, figures and forecasts on the global medical markets. ... categories the Worldwide Medical Market Forecasts to 2019 ... on the worldwide medical market to reveal key insights ... data for 2010-2019, covering each country market individually, allowing ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)...   Surefire Medical , Inc., the developer of ... targeted delivery of embolization agents in minimally invasive direct-to-tumor ... John R. Daniels , MD of the University of ... Steven C. Katz , MD of the Roger ... Board (SAB).    "The role of the ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: